« Back Nanomedicine: Nanotechnology, Biology and Medicine

Article in Press

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells

  • Hongyong Zhang, DVM, PhD

      Affiliations

    • Department of Internal Medicine, Division of Hematology/Oncology, University of California at Davis, Sacramento, California
  • ,
  • Juntao Luo, PhD

      Affiliations

    • Department of Biochemistry and Molecular Medicine, University of California–Davis, Sacramento, California
  • ,
  • Yuanpei Li, PhD

      Affiliations

    • Department of Biochemistry and Molecular Medicine, University of California–Davis, Sacramento, California
  • ,
  • Paul T. Henderson, PhD

      Affiliations

    • Department of Internal Medicine, Division of Hematology/Oncology, University of California at Davis, Sacramento, California
  • ,
  • Yanchun Wang, PhD

      Affiliations

    • Department of Internal Medicine, Division of Hematology/Oncology, University of California at Davis, Sacramento, California
  • ,
  • Sebastian Wachsmann-Hogiu, PhD

      Affiliations

    • Center for Biophotonics Science and Technology, University of California–Davis, Sacramento, California
  • ,
  • Weixin Zhao, MD, PhD

      Affiliations

    • Shanghai Cancer Hospital, Fudan University, Shanghai, China
  • ,
  • Kit S. Lam, MD, PhD

      Affiliations

    • Department of Internal Medicine, Division of Hematology/Oncology, University of California at Davis, Sacramento, California
    • Department of Biochemistry and Molecular Medicine, University of California–Davis, Sacramento, California
  • ,
  • Chong-xian Pan, MD, PhD

      Affiliations

    • Department of Internal Medicine, Division of Hematology/Oncology, University of California at Davis, Sacramento, California
    • Department of Urology, University of California–Davis, Sacramento, California
    • VA Northern California Health Care System, Mather, California
    • Corresponding Author InformationCorresponding author: University of California–Davis Cancer Center, 4501 X Street, Room 3016, Sacramento, California 95817, USA.

Received 21 February 2011 ,Accepted 11 December 2011. Published online 26 December 2011 Corrected Proof

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This project is supported by the California Institute for Regenerative Medicine New Faculty Award (C-X.P.).

PII: S1549-9634(11)00600-9

doi: 10.1016/j.nano.2011.12.004

« Back Nanomedicine: Nanotechnology, Biology and Medicine

Article in Press